9.2 C
London
Friday, November 8, 2024
Subscribe
HomeTagsHighTide

Tag: HighTide

spot_imgspot_img
Business

EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, presents...
Business

HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate...

ROCKVILLE, MD and SHENZHEN, CHINA, June 21, 2024 - (ACN Newswire) - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development...
Business

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

HighTide Therapeutics Inc. ("HighTide"), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced the closing of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img

Company

Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click.

Latest

Popular

Sitemap

© 2004-2024 Webnewswire, All Rights Reserved